RMD — ResMed Inc. stock price, charts and financials

QT40ResMed Inc.

ResMed Inc. (NYSE: RMD) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
223.14
+7.95+3.69%
RMDQT40ResMed Inc.·NYSE
223.14+3.69%
Earnings
Up 3.7% — Earnings due 2026-08-06 — pre-report positioning.
Medium confidence
TA
Loading chart...
Screen all →
Snapshot
IndexS&P 500P/E21.58EPS (ttm)10.34Insider Own0.95%Shs Outstand145.06MPerf Week6.79%
Market Cap32.37BForward P/E16.83EPS next Y13.26Insider Trans-2.76%Shs Float144.16MPerf Month2.17%
Enterprise Value31.52BPEG2.11EPS next Q-Inst Own-Short Float9.39%Perf Quarter6.55%
Income1.52BP/S5.84EPS this Y16.62%Inst Trans-Short Ratio8.74Perf Half Y-12.40%
Sales5.54BP/B4.99EPS next Y9.97%ROA17.30%Short Interest13.54MPerf YTD-7.36%
Book/sh44.76P/C19.49EPS next 5Y10.23%ROE24.41%52W High293.80 -24.05%Perf Year-20.08%
Cash/sh11.45P/FCF17.51EPS past 3/5Y21.52% 17.37%ROIC19.63%52W Low180.27 23.78%Perf 3Y-0.01%
Dividend Est.2.40 (1.08%)EV/EBITDA14.43Sales past 3/5Y12.88% 11.72%Gross Margin61.69%Volatility3.38% 2.91%Perf 5Y-15.55%
Dividend TTM2.40 (1.08%)EV/Sales5.69EPS Y/Y TTM49.42%Oper. Margin34.28%ATR (14)6.99Perf 10Y240.62%
Dividend Ex-DateMay 14, 2026Quick Ratio2.33Sales Y/Y TTM18.21%Profit Margin27.44%RSI (14)65.85Recom2.74
Dividend Gr. 3/5Y9.53% 7.70%Current Ratio3.01EPS Q/Q17.70%SMA209.69%Beta0.75Target Price242.22
Payout22.39%Debt/Eq0.14Sales Q/Q10.76%SMA5011.79%Rel Volume1.16Prev Close215.19
Employees10,600LT Debt/Eq0.14EarningsAug 06SMA200-3.61%Avg Volume1.49MPrice223.14
IPO DateJun 02, 1995Option/ShortYes / YesEPS/Sales Surpr.2.32% 0.81%Net Debt/EBITDA-0.37Volume1,725,513Change3.69%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedUBSBuy$345$300
Jul-16-26ReiteratedRBC CapitalOutperform$276$234
Jul-15-26ReiteratedMizuhoOutperform$265$220
Jul-13-26DowngradeCitigroupBuyNeutral
Jul-10-26ReiteratedJefferiesHold$240$225
Jul-08-26ReiteratedRBC CapitalOutperform$314$276
Jul-08-26ReiteratedWells FargoEqual Weight$280$225
Jun-22-26ReiteratedKeybancOverweight$290$266
Jun-17-26DowngradeMorgan StanleyOverweightEqual Weight$305$230
May-01-26ReiteratedRobert W. Baird$254$225
Latest News
Aug-04-26
Aug-03-26
Jul-31-26
Jul-30-26
Jul-28-26
Jul-23-26
Jul-21-26
Jul-14-26
Jul-13-26
Jul-10-26
Jul-09-26
Jul-09-2602:03PM
Jul-08-26
Company

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
6/30/2025
FY 2024
6/30/2024
FY 2023
6/30/2023
FY 2022
6/30/2022
FY 2021
6/30/2021
FY 2020
6/30/2020
FY 2019
6/30/2019
FY 2018
6/30/2018
Total Revenue5,5385,1464,6854,2233,5783,1972,9572,6072,340
Cost of Goods Sold Incl. D&A2,1212,0912,0301,8671,5541,3581,2391,070978
Gross Profit3,4173,0552,6552,3562,0241,8391,7181,5371,362
Selling, General and Administrative Excl. Other1,082991917874739670677645600
Research and Development358331308288254225202181155
Other Operating Expense78481106231403013165
Operating Income1,9001,6851,3201,1321,000904810579542
Interest Expense291346472224403628
Unusual Expense
Non-Operating Income (Expense)355-917-174-36-248
Net Income Before Taxes1,9031,6781,2651,102960884733519521
Income Taxes384277244204181409111114206
Consolidated Net Income1,5211,4011,021898779475622405316
Net Income From Continuing Operations1,5211,4011,021898779475622405316
Net Income1,5211,4011,021898779475622405316
EPS (Recurring)10.389.556.946.125.343.274.312.832.21
EPS (Basic, Before Extraordinaries)10.389.556.946.125.343.274.312.832.21
EPS (Diluted)10.349.516.926.095.303.244.272.802.19
EBITDA2,1851,9131,5341,3591,1771,104990706680
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio21.5827.1327.6635.8839.5576.0944.9643.5847.30
Price To Sales Ratio5.887.376.017.618.5511.189.356.696.33
Gross Margin61.7059.3756.6755.7956.5757.5258.1058.9658.21
Operating Margin34.3132.7428.1826.8127.9528.2827.3922.2123.16
Net Margin27.4627.2321.7921.2621.7714.8621.0315.5413.50
Shares Outstanding146147147147146145144143143
Market Capitalization32,57837,92628,13932,12030,60635,74527,64817,45014,812
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$310.37$274.32$238.28$202.23$166.18 Close Price0.00M0.97M1.95M2.92M3.89MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Farrell Michael J.Chairman and CEOJul 07 '26Option Exercise146.344,991730,383471,214Jul 09
Farrell Michael J.Chairman and CEOJul 07 '26Sale218.554,9911,090,771466,223Jul 09
Farrell Michael J.Chairman and CEOJun 08 '26Option Exercise146.344,991730,383471,214Jun 09
Farrell Michael J.Chairman and CEOJun 08 '26Sale193.964,991968,064466,256Jun 09
Farrell Michael J.Chairman and CEOMay 07 '26Option Exercise146.344,991730,383471,214May 11
Farrell Michael J.Chairman and CEOMay 07 '26Sale207.824,9911,037,233466,223May 11
Farrell Michael J.Chairman and CEOApr 07 '26Option Exercise146.344,991730,383471,214Apr 09
Farrell Michael J.Chairman and CEOApr 07 '26Sale225.504,9911,125,486466,223Apr 09
Sandercock BrettChief Financial OfficerApr 01 '26Sale224.311,000224,31083,495Apr 03
FARRELL PETER CDirectorApr 01 '26Sale225.002,000450,00060,773Apr 02
Farrell Michael J.Chairman and CEOMar 09 '26Option Exercise146.344,991730,383471,214Mar 11
Farrell Michael J.Chairman and CEOMar 09 '26Sale251.034,9911,252,902466,223Mar 11
FARRELL PETER CDirectorMar 04 '26Sale260.222,000520,44062,773Mar 05
Sandercock BrettChief Financial OfficerMar 02 '26Sale254.301,000254,30084,495Mar 03
Farrell Michael J.Chairman and CEOFeb 09 '26Option Exercise146.344,991730,383471,214Feb 10
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.